The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg.
Front Immunol
2023
14
Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany.
BMC Med Ethics
2023
24
1
Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties.
Clin Chem Lab Med
2023
61
7
1255-1265
Toward SERS-based therapeutic drug monitoring in clinical settings: Recent developments and trends
Trends Analyt Chem
2023
164
Congress report: 5th Munich POCT Symposium, September 27-29, 2022, Klinikum Rechts der Isar of the TU Munich
J. Lab. Med.
2023
47
2
87-95
Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination.
Blood Adv
2023
7
10
2214-2227
Classification of "Near-patient" and "Point-of-Care" SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities.
J Clin Virol
2023
165
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.
Psychopharmacology (Berl)
2023
240
4
899-908
The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Eur J Immunol
2023
53
3
CLEC12A Binds to Legionella pneumophila but Has No Impact on the Host's Antibacterial Response.
Int J Mol Sci
2023
24
4